Ted M. Ross

Affiliated with

Research Area

Biography

Ted M. Ross has not added Biography.
If you are Ted M. Ross and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 27	2016

Other Publications

Article	Year
Enhancement of antibodies to the human immunodeficiency virus type 1 envelope by using the molecular adjuvant C3d. Journal of virology\| PubMed ID: 12525639	2003
Induction of heterosubtypic immunity to influenza A virus using a DNA vaccine expressing hemagglutinin-C3d fusion proteins. Vaccine\| PubMed ID: 12547601	2003
Impact of glycosylation on the immunogenicity of a DNA-based influenza H5 HA vaccine. Virology\| PubMed ID: 12706077	2003
Particle-based vaccines for HIV-1 infection. Current drug targets. Infectious disorders\| PubMed ID: 12769792	2003
Protection against influenza virus infection by intranasal administration of C3d-fused hemagglutinin. Vaccine\| PubMed ID: 14575764	2003
Generation and characterization of the humoral immune response to DNA immunization with a chimeric beta-amyloid-interleukin-4 minigene. European journal of immunology\| PubMed ID: 14635031	2003
Independent but not synergistic enhancement to the immunogenicity of DNA vaccine expressing HIV-1 gp120 glycoprotein by codon optimization and C3d fusion in a mouse model. Vaccine\| PubMed ID: 15068860	2004
Mouse strain-dependent differences in enhancement of immune responses by C3d. Vaccine\| PubMed ID: 15068861	2004
Elicitation of neutralizing antibodies with DNA vaccines expressing soluble stabilized human immunodeficiency virus type 1 envelope glycoprotein trimers conjugated to C3d. Journal of virology\| PubMed ID: 15078953	2004
Cutting edge: C3d functions as a molecular adjuvant in the absence of CD21/35 expression. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 15128761	2004
Characterization of a DNA vaccine expressing a human immunodeficiency virus-like particle. Virology\| PubMed ID: 15351214	2004
DNA vaccines expressing soluble CD4-envelope proteins fused to C3d elicit cross-reactive neutralizing antibodies to HIV-1. Virology\| PubMed ID: 15464849	2004
Multiple residues in the extracellular domains of CCR3 are critical for coreceptor activity. Virology\| PubMed ID: 15476879	2004
Unique V3 loop sequence derived from the R2 strain of HIV-type 1 elicits broad neutralizing antibodies. AIDS research and human retroviruses\| PubMed ID: 15588348	2004
C3d enhances immune responses using low doses of DNA expressing the HIV-1 envelope from codon-optimized gene sequences. Current HIV research\| PubMed ID: 15853723	2005
Elicitation of immunity to HIV type 1 Gag is determined by Gag structure. AIDS research and human retroviruses\| PubMed ID: 16438652	2006
HIV-1 Envgp140 trimers elicit neutralizing antibodies without efficient induction of conformational antibodies. Vaccine\| PubMed ID: 16621193	2006
A minimum CR2 binding domain of C3d enhances immunity following vaccination. Advances in experimental medicine and biology\| PubMed ID: 16893077	2006
Virus-like particles: designing an effective AIDS vaccine. Methods (San Diego, Calif.)\| PubMed ID: 16997718	2006
Membrane embedded HIV-1 envelope on the surface of a virus-like particle elicits broader immune responses than soluble envelopes. Virology\| PubMed ID: 17011011	2007
Lentivirus-like particles without reverse transcriptase elicit efficient immune responses. Current HIV research\| PubMed ID: 17073623	2006
Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine\| PubMed ID: 17337102	2007
Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity. Immunologic research\| PubMed ID: 17337780	2006
Reduction of anti-HIV-1 Gag immune responses during co-immunization: immune interference by the HIV-1 envelope. Current HIV research\| PubMed ID: 17346134	2007
Developing broadly reactive HIV-1/AIDS vaccines: a review of polyvalent and centralized HIV-1 vaccines. Current pharmaceutical design\| PubMed ID: 17627529	2007
Mucosal vaccine vectors: replication-competent versus replication-deficient poxviruses. Current pharmaceutical design\| PubMed ID: 17627535	2007
Immunostimulant adjuvant patch enhances humoral and cellular immune responses to DNA immunization. DNA and cell biology\| PubMed ID: 17961074	2008
Antibody neutralization. Current HIV research\| PubMed ID: 18045107	2007
Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PloS one\| PubMed ID: 18231588	2008
HIV genes diversify in B cells. Current HIV research\| PubMed ID: 18288970	2008
A bivalent influenza VLP vaccine confers complete inhibition of virus replication in lungs. Vaccine\| PubMed ID: 18468740	2008
H5N1 VLP vaccine induced protection in ferrets against lethal challenge with highly pathogenic H5N1 influenza viruses. Vaccine\| PubMed ID: 18706956	2008
DNA epitope vaccine containing complement component C3d enhances anti-amyloid-beta antibody production and polarizes the immune response towards a Th2 phenotype. Journal of neuroimmunology\| PubMed ID: 18838175	2008
Elicitation of protective immune responses using a bivalent H5N1 VLP vaccine. Virology journal\| PubMed ID: 18957098	2008
Viral sequence diversity: challenges for AIDS vaccine designs. Expert review of vaccines\| PubMed ID: 18980542	2008
Simian immunodeficiency virus pathogenesis. Current HIV research\| PubMed ID: 19149548	2009
The role of RNA folding free energy in the evolution of the polymerase genes of the influenza A virus. Genome biology\| PubMed ID: 19216739	2009
Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines. Vaccine\| PubMed ID: 19389453	2009
A trivalent virus-like particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets. PloS one\| PubMed ID: 19554101	2009
Critical role of IL-17RA in immunopathology of influenza infection. Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 19783685	2009
Impaired immune responses in the lungs of aged mice following influenza infection. Respiratory research\| PubMed ID: 19922665	2009
C3d adjuvant activity is reduced by altering residues involved in the electronegative binding of C3d to CR2. Immunology letters\| PubMed ID: 20064559	2010
Animal lentiviruses. Editorial. Current HIV research\| PubMed ID: 20238449	2010
Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology\| PubMed ID: 20334888	2010
Enhancement of anti-DIII antibodies by the C3d derivative P28 results in lower viral titers and augments protection in mice. Virology journal\| PubMed ID: 20462412	2010
West Nile virus. Clinics in laboratory medicine\| PubMed ID: 20513541	2010
Dengue virus. Clinics in laboratory medicine\| PubMed ID: 20513545	2010
Vaccination with DNA plasmids expressing Gn coupled to C3d or alphavirus replicons expressing gn protects mice against Rift Valley fever virus. PLoS neglected tropical diseases\| PubMed ID: 20582312	2010
Properly folded bacterially expressed H1N1 hemagglutinin globular head and ectodomain vaccines protect ferrets against H1N1 pandemic influenza virus. PloS one\| PubMed ID: 20634959	2010
Seroprevalence following the second wave of Pandemic 2009 H1N1 influenza in Pittsburgh, PA, USA. PloS one\| PubMed ID: 20644650	2010
Hemagglutinin displayed baculovirus protects against highly pathogenic influenza. Vaccine\| PubMed ID: 20727393	2010
Bacterial HA1 vaccine against pandemic H5N1 influenza virus: evidence of oligomerization, hemagglutination, and cross-protective immunity in ferrets. Journal of virology\| PubMed ID: 21084473	2011
Vaccination of patients with mild and severe asthma with a 2009 pandemic H1N1 influenza virus vaccine. The Journal of allergy and clinical immunology\| PubMed ID: 21145578	2011
Challenges in improving influenza vaccine protection in the elderly. Expert review of vaccines\| PubMed ID: 21162614	2011
A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets. Vaccine\| PubMed ID: 21320540	2011
An agent-based model of inflammation and fibrosis following particulate exposure in the lung. Mathematical biosciences\| PubMed ID: 21385589	2011
Acute murine H5N1 influenza A encephalitis. Brain pathology (Zurich, Switzerland)\| PubMed ID: 21714828	2012
Large scale comparison of innate responses to viral and bacterial pathogens in mouse and macaque. PloS one\| PubMed ID: 21789257	2011
Baculovirus-produced influenza virus-like particles in mammalian cells protect mice from lethal influenza challenge. Viral immunology\| PubMed ID: 21830902	2011
Adjuvants that stimulate TLR3 or NLPR3 pathways enhance the efficiency of influenza virus-like particle vaccines in aged mice. Vaccine\| PubMed ID: 21963872	2011
Prevalence of antibodies against seasonal influenza A and B viruses during the 2009-2010 and 2010-2011 influenza seasons in residents of Pittsburgh, PA, USA. PLoS currents\| PubMed ID: 22037352	2011
Animal models of Rift Valley fever virus infection. Virus research\| PubMed ID: 22086058	2012
Absence of fetal transmission of H1N1 despite severe maternal infection. Influenza and other respiratory viruses\| PubMed ID: 22103260	2012
Elicitation of anti-1918 influenza virus immunity early in life prevents morbidity and lower levels of lung infection by 2009 pandemic H1N1 influenza virus in aged mice. Journal of virology\| PubMed ID: 22130546	2012
Antibody breadth and protective efficacy are increased by vaccination with computationally optimized hemagglutinin but not with polyvalent hemagglutinin-based H5N1 virus-like particle vaccin... Clinical and vaccine immunology : CVI\| PubMed ID: 22190399	2012
Evaluation of heterologous vaginal SHIV SF162p4 infection following vaccination with a polyvalent Clade B virus-like particle vaccine. AIDS research and human retroviruses\| PubMed ID: 22214267	2012
Influenza virus H1N1pdm09 infections in the young and old: evidence of greater antibody diversity and affinity for the hemagglutinin globular head domain (HA1 Domain) in the elderly than in ... Journal of virology\| PubMed ID: 22379097	2012
Computationally optimized antigens to overcome influenza viral diversity. Expert review of vaccines\| PubMed ID: 22380818	2012
Plasmacytoid dendritic cell depletion leads to an enhanced mononuclear phagocyte response in lungs of mice with lethal influenza virus infection. Comparative immunology, microbiology and infectious diseases\| PubMed ID: 22421538	2012
A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection. The Journal of infectious diseases\| PubMed ID: 22448011	2012
Complex patterns of human antisera reactivity to novel 2009 H1N1 and historical H1N1 influenza strains. PloS one\| PubMed ID: 22815705	2012
Oligomeric recombinant H5 HA1 vaccine produced in bacteria protects ferrets from homologous and heterologous wild-type H5N1 influenza challenge and controls viral loads better than subunit H... Journal of virology\| PubMed ID: 22951833	2012
Sequential seasonal H1N1 influenza virus infections protect ferrets against novel 2009 H1N1 influenza virus. Journal of virology\| PubMed ID: 23115287	2013
Sequencing, annotation, and characterization of the influenza ferret infectome. Journal of virology\| PubMed ID: 23236062	2013
Rhesus macaques vaccinated with consensus envelopes elicit partially protective immune responses against SHIV SF162p4 challenge. Virology journal\| PubMed ID: 23548077	2013
Intranasal antibody gene transfer in mice and ferrets elicits broad protection against pandemic influenza. Science translational medicine\| PubMed ID: 23720583	2013
Immune history shapes specificity of pandemic H1N1 influenza antibody responses. The Journal of experimental medicine\| PubMed ID: 23857983	2013
Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice. Human vaccines & immunotherapeutics\| PubMed ID: 24045788	2013
Mucosal pre-exposure to Th17-inducing adjuvants exacerbates pathology after influenza infection. The American journal of pathology\| PubMed ID: 24183780	2014
A novel nonhuman primate model for influenza transmission. PloS one\| PubMed ID: 24244352	2013
A novel outbred mouse model of 2009 pandemic influenza and bacterial co-infection severity. PloS one\| PubMed ID: 24324838	2013
H1N1, but not H3N2, influenza A virus infection protects ferrets from H5N1 encephalitis. Journal of virology\| PubMed ID: 24371072	2014
Massive mobilization of dendritic cells during influenza A virus subtype H5N1 infection of nonhuman primates. The Journal of infectious diseases\| PubMed ID: 24403559	2014
Effects of aging on influenza virus infection dynamics. Journal of virology\| PubMed ID: 24478442	2014
Cross-conservation of T-cell epitopes: now even more relevant to (H7N9) influenza vaccine design. Human vaccines & immunotherapeutics\| PubMed ID: 24525618	2014
Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50-80 years of age... Human vaccines & immunotherapeutics\| PubMed ID: 24614078	2014
Eliciting broadly protective antibody responses against influenza. Current opinion in immunology\| PubMed ID: 24632083	2014
Influenza virus infection elicits protective antibodies and T cells specific for host cell antigens also expressed as tumor-associated antigens: a new view of cancer immunosurveillance. Cancer immunology research\| PubMed ID: 24778322	2014
Use of transmission electron microscopy to identify nanocrystals of challenging protein targets. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 24872454	2014
A polyvalent Clade B virus-like particle HIV vaccine combined with partially protective oral preexposure prophylaxis prevents simian-human immunodeficiency virus Infection in macaques and pr... AIDS research and human retroviruses\| PubMed ID: 24914761	2014
Challenges and future in vaccines, drug development, and immunomodulatory therapy. Annals of the American Thoracic Society\| PubMed ID: 25148426	2014
H5 N-terminal β sheet promotes oligomerization of H7-HA1 that induces better antibody affinity maturation and enhanced protection against H7N7 and H7N9 viruses compared to inactivated influe... Vaccine\| PubMed ID: 25284811	2014
Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 25331901	2014
C3d adjuvant effects are mediated through the activation of C3d-specific autoreactive T cells. Immunology and cell biology\| PubMed ID: 25385064	2015
Cross-protection against H7N9 influenza strains using a live-attenuated H7N3 virus vaccine. Vaccine\| PubMed ID: 25448100	2015
Randomized, controlled trial of high-dose influenza vaccine among frail residents of long-term care facilities. The Journal of infectious diseases\| PubMed ID: 25525051	2015
Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades. Human vaccines & immunotherapeutics\| PubMed ID: 25671661	2015
The inflammatory response to influenza A virus (H1N1): An experimental and mathematical study. Journal of theoretical biology\| PubMed ID: 25843213	2015
Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season. Cell reports\| PubMed ID: 26119736	2015
Enhanced Influenza Virus-Like Particle Vaccination with a Structurally Optimized RIG-I Agonist as Adjuvant. Journal of virology\| PubMed ID: 26269188	2015
Emerging Infections of CNS: Avian Influenza A Virus, Rift Valley Fever Virus and Human Parechovirus. Brain pathology (Zurich, Switzerland)\| PubMed ID: 26276027	2015
Portrait of Dr. Ted M. Ross. Human vaccines & immunotherapeutics\| PubMed ID: 26552916	2016
Sequential Infection in Ferrets with Antigenically Distinct Seasonal H1N1 Influenza Viruses Boosts Hemagglutinin Stalk-Specific Antibodies. Journal of virology\| PubMed ID: 26559834	2016
Use of computational and recombinant technologies for developing novel influenza vaccines. Expert review of vaccines\| PubMed ID: 26595182	2016
Are plasma mineral levels related to antibody response to influenza vaccination in older adults? Human vaccines & immunotherapeutics\| PubMed ID: 26751915	2016
Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses. Journal of virology\| PubMed ID: 26912624	2016
Delta inulin-derived adjuvants that elicit Th1 phenotype following vaccination reduces respiratory syncytial virus lung titers without a reduction in lung immunopathology. Human vaccines & immunotherapeutics\| PubMed ID: 27215855	2016